Skip to content
  • Articles
  • SmartPill
  • FastPoll
  • HealthyDose
  • Contact Us
  • About InsightCity
  • Search

stat_4-24-17

Posted on April 23, 2017Full size 600 × 210

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Related

Post navigation

Previous Previous post: SmartPill™ for the Week of April 24, 2017

Sign up for our newsletter

SmartPill™ for the Week of October 16, 2017

Weight and children:

Source: Imperial College London and WHO

  • SmartPill™ for the Week of October 16, 2017
    Weight and children: Source: Imperial College […]
  • SmartPill™ for the Week of October 9, 2017
    Internet pharmacies: Source: US General […]
  • SmartPill™ for the Week of October 2, 2017
    Societal cost savings from weight loss: Source: […]
  • SmartPill™ for the Week of September 24, 2017
    Genetic mutations: Source: Nature via The […]
  • SmartPill™ for the Week of September 18, 2017
    T. gondii prevalence: Source: Genetic Engineering […]

FastPoll™ for the Week of October 9, 2017

Ok, you get one pick. Which country’s health system do you choose?

  • FastPoll™ for the Week of October 9, 2017
    Ok, you get one pick. Which country’s health system do you choose? Now don't be stingy. Share this. […]
  • FastPoll™ for the Week of October 2, 2017
    Which brand of cereal would you be most likely to eat? Now don't be stingy. Share this. Related […]
  • FastPoll™ for the Week of September 25, 2017
    Tell us about your fitness device use… Now don't be stingy. Share this. Related […]
  • FastPoll™ for the Week of September 18, 2017
    How would you feel about more SoapboxWarnings™ in future InsightCity newsletters? Now don't be […]
  • FastPoll™ for the Week of September 11, 2017
    Have you ever been laid off (not fired for cause) from a job? Now don't be stingy. Share this. […]

Tags

AbbVie addiction advertising alcohol allergan Alzheimer’s disease Amazon Amgen antibiotic resistance antibiotics apps bacteria biologics biosimilars cancer clinical trials data depression diabetes diet direct to consumer drug approvals Drug Pricing electronic health records exercise FDA fitness generics genetics GSK healthcare healthcare costs HIV hospitals immunotherapy Innovation insurance lawsuits M&A malaria medical device Medicare Merck Mylan NHS Novartis obesity oncology opioids patients pfizer pharma Phase I physicians prescriptions pricing public health regulation regulatory research Sanofi smoking social media stem cells stroke technology Teva Trump UK vaccines wearables weight loss WHO youth zika

Sign up for updates

Contact us

[email protected] | 919-230-6767
Theme: Maisha Lite designed by Anariel Design.